How We Work Together
Every project starts with a free 30-minute call to understand your data, your questions, and your timeline. From there, I will scope a project that fits.
Focused Analysis
Starting at $3,500
1-2 weeks
Ideal for
- Single-dataset analysis (scRNA-seq, flow cytometry, bulk RNA-seq)
- Publication-ready figures from existing data
- Statistical analysis for a manuscript revision
- Quick QC and exploratory analysis
You get
- Analysis report with figures
- Documented code and scripts
- 30-minute results walkthrough
Full Pipeline
Starting at $8,000
3-6 weeks
Ideal for
- End-to-end scRNA-seq or multi-omic pipeline builds
- ML model development for your biological data
- Rebuilding a fragile or undocumented pipeline
- Multi-dataset integration and comparative analysis
You get
- Everything in Focused Analysis
- Reproducible, version-controlled pipeline
- Full documentation and handoff
- Two rounds of revision
Ongoing Partnership
Starting at $3,000/mo
Monthly retainer
Ideal for
- Biotech startups without in-house bioinformatics
- Labs with ongoing data generation
- Multi-experiment studies needing consistent analysis
- Grant-funded projects needing computational support
You get
- Dedicated hours each month (typically 15-25 hrs)
- Priority turnaround on requests
- Slack or Teams access for async communication
- Monthly strategy calls
Not sure which tier fits? That is exactly what the 30-minute call is for. No pitch, no pressure, just a conversation about your data and what you need.
Common Questions
What if my project doesn't fit neatly into a tier?
Most don't, and that's fine. These are starting points. I'll scope a custom proposal based on your specific data and questions after our initial call.
Do you work with confidential or proprietary data?
Yes. I sign NDAs as standard practice and can work within your institution's data governance requirements. All data is handled on secure, encrypted infrastructure.
Can you be listed as a contributor on publications?
If the analytical contribution warrants it under ICMJE guidelines, absolutely. We can discuss authorship expectations upfront.
I'm a startup. Do you offer equity-based arrangements?
I'm open to hybrid cash and equity structures for the right early-stage companies. Let's discuss during the call.
Ready to scope your project?
Book a free 30-minute call and we will figure out the best path forward for your data.
Book a Free 30-Minute Call